The American Hospital Association is partnering with Epic on the Safer Births Postpartum Hemorrhage Collaborative, a ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

VanEck Pharmaceutical ETF (NYSEARCA:PPH) exists to give investors broad exposure to the global pharmaceutical industry ...

As if giving birth isn’t difficult enough, about 14 million women each year lose a significant amount of blood within 24 hours of delivery — a condition called postpartum hemorrhage (PPH). It’s more ...

VanEck Pharmaceutical ETF offers focused exposure to large-cap pharmaceutical companies, benefiting from strong long-term demographic and innovation trends. PPH's high concentration in top holdings ...

Woman’s Hospital is bringing the Oli wearable sensor device into clinical use as part of an international research study.

Pharmaceuticals underperformed the S&P 500 in 2023 but have been outperforming the broader market in 2024. The PPH fund offers exposure to pharmaceutical stocks and has outperformed its peers in terms ...

Big pharma stocks, as measured by the VanEck Pharmaceutical ETF (PPH), plunged Monday morning then recovered in afternoon trading as investors reacted to mixed messages about President Donald Trump’s ...

“PPH requests appear to have been filed for less than 1% of U.S. applications. Why are applicants foregoing the program? While the program does not require payment of a fee per se, the author proposes ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

VanEck Pharmaceutical ETF (PPH) is 17.91% concentrated in Eli Lilly (LLY), which has fallen 16% year-to-date as generic GLP-1 competition and patent expirations in emerging markets threaten pricing ...